Oliver Luxxe Assets’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.98M | Buy |
65,102
+689
| +1% | +$84.5K | 1.42% | 12 |
|
2025
Q1 | $6.52M | Sell |
64,413
-59,593
| -48% | -$6.04M | 1.21% | 20 |
|
2024
Q4 | $11.7M | Buy |
124,006
+63,453
| +105% | +$5.99M | 1.04% | 27 |
|
2024
Q3 | $5.85M | Buy |
60,553
+18,407
| +44% | +$1.78M | 1.05% | 29 |
|
2024
Q2 | $3.62M | Buy |
42,146
+564
| +1% | +$48.4K | 0.77% | 49 |
|
2024
Q1 | $3.43M | Buy |
41,582
+348
| +0.8% | +$28.7K | 0.72% | 55 |
|
2023
Q4 | $2.75M | Sell |
41,234
-3,262
| -7% | -$218K | 0.65% | 57 |
|
2023
Q3 | $2.99M | Buy |
44,496
+25,235
| +131% | +$1.69M | 0.77% | 45 |
|
2023
Q2 | $1.3M | Buy |
19,261
+540
| +3% | +$36.6K | 0.33% | 83 |
|
2023
Q1 | $1.01M | Buy |
18,721
+9,723
| +108% | +$526K | 0.27% | 86 |
|
2022
Q4 | $538K | Buy |
+8,998
| New | +$538K | 0.15% | 126 |
|
2019
Q1 | – | Sell |
-4,508
| Closed | -$221K | – | 118 |
|
2018
Q4 | $221K | Sell |
4,508
-91
| -2% | -$4.46K | 0.15% | 95 |
|
2018
Q3 | $281K | Buy |
+4,599
| New | +$281K | 0.16% | 88 |
|